GFAFX
Price
$74.56
Change
+$0.67 (+0.91%)
Updated
Dec 20 closing price
TGVFX
Price
$51.29
Change
+$0.58 (+1.14%)
Updated
Dec 20 closing price
Ad is loading...

GFAFX vs TGVFX

Header iconGFAFX vs TGVFX Comparison
Open Charts GFAFX vs TGVFXBanner chart's image
American Funds Growth Fund of Amer F1
Price$74.56
Change+$0.67 (+0.91%)
VolumeN/A
CapitalizationN/A
Touchstone Growth Opportunities A
Price$51.29
Change+$0.58 (+1.14%)
VolumeN/A
CapitalizationN/A
GFAFX vs TGVFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFAFX vs. TGVFX commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFAFX is a Buy and TGVFX is a Buy.

FUNDAMENTALS
Fundamentals
GFAFX has more cash in the bank: 301B vs. TGVFX (172M). GFAFX pays higher dividends than TGVFX: GFAFX (0.45) vs TGVFX (0.00). GFAFX was incepted earlier than TGVFX: GFAFX (24 years) vs TGVFX (29 years). TGVFX is a more actively managed with annual turnover of: 55.00 vs. GFAFX (31.00). GFAFX has a lower initial minimum investment than TGVFX: GFAFX (250) vs TGVFX (2500). TGVFX annual gain was more profitable for investors over the last year : 26.92 vs. GFAFX (19.89). TGVFX return over 5 years is better than : 55.17 vs. GFAFX (48.17).
GFAFXTGVFXGFAFX / TGVFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years29 years-
Gain YTD19.46726.61173%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets301B172M175,000%
Annual Yield % from dividends0.450.00-
Returns for 1 year19.8926.9274%
Returns for 3 years4.2625.0617%
Returns for 5 years48.1755.1787%
Returns for 10 years76.3659.41129%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SYF65.451.18
+1.84%
Synchrony Financial
UAN74.211.00
+1.37%
CVR Partners LP
ASB23.990.29
+1.22%
Associated Banc-Corp
CMPX1.380.01
+0.73%
Compass Therapeutics
VRME0.63N/A
-0.11%
VerifyMe